Cargando…
Estrogen Inhibits Renal Cell Carcinoma Cell Progression through Estrogen Receptor-β Activation
Renal cell carcinoma (RCC) originates in the lining of the proximal convoluted tubule and accounts for approximately 3% of adult malignancies. The RCC incidence rate increases annually and is twofold higher in males than in females. Female hormones such as estrogen may play important roles during RC...
Autores principales: | Yu, Cheng-Ping, Ho, Jar-Yi, Huang, Yi-Ting, Cha, Tai-Lung, Sun, Guang-Huan, Yu, Dah-Shyong, Chang, Fung-Wei, Chen, Shu-Pin, Hsu, Ren-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584057/ https://www.ncbi.nlm.nih.gov/pubmed/23460808 http://dx.doi.org/10.1371/journal.pone.0056667 |
Ejemplares similares
-
Ovatodiolide Targets β-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma
por: Ho, Jar-Yi, et al.
Publicado: (2013) -
WNT10A Plays an Oncogenic Role in Renal Cell Carcinoma by Activating WNT/β-catenin Pathway
por: Hsu, Ren-Jun, et al.
Publicado: (2012) -
Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway
por: Ho, Jar-Yi, et al.
Publicado: (2016) -
Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals
por: Yeh, Chiuan-Ren, et al.
Publicado: (2015) -
Estrogen Enhances the Expression of the Multidrug Transporter Gene ABCG2—Increasing Drug Resistance of Breast Cancer Cells through Estrogen Receptors
por: Chang, Fung-Wei, et al.
Publicado: (2017)